Executive Director & Principal at The Sage Group
Since 2007 Mr. Casamento has been executive director and principal of The Sage Group, a health care advisory group. He was president and CEO of Osteologix from October 2004 until April 2007. Mr. Casamento was the founder of Questcor Pharmaceuticals where he was president, CEO and chairman. In 2014 Questcor was acquired by Mallinckrodt for approximately $6 Billion. At RiboGene Inc. he was president, CEO and chairman and he was also co-founder, president and CEO of Indevus (formerly Interneuron Pharmaceuticals). Indevus was eventually acquired by Endo for approximately $800 Million. He has held senior management positions at Genzyme Corporation, where he was Senior Vice President and General Manager for Biochemicals and Pharmaceuticals, American Hospital Supply, where he was Vice President of Business Development for the Critical Care Division, Johnson & Johnson, Hoffmann-LaRoche and Sandoz. During his career he has been a Director of eleven other pharmaceutical/biotechnology companies and has been on the board of two not for profit organizations. He holds a bachelor’s degree in Pharmacy from Fordham University and an M.B.A. from Iona College. Mr. Casamento also serves as the Chairman of the company’s Audit Committee.
Source: Relmada Therapeutics, Inc. on 01/18/2023
By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Charles J. Casamento. More specifically, you'll be able to:
Access over 1,500,000 executive and board member profiles.
Example: Charles J. Casamento